Literature DB >> 27867986

The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas.

Joseph R Keen1, Sharon A Swanger2, Stephen F Traynelis2, Jeffrey J Olson1.   

Abstract

Entities:  

Year:  2016        PMID： 27867986      PMCID： PMC5104636          DOI： 10.21037/atm.2016.10.23

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  11 in total

1.  Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.

Authors:  Eduard H Panosyan; Joseph L Lasky; Henry J Lin; Albert Lai; Yang Hai; Xiuqing Guo; Michael Quinn; Stanley F Nelson; Timothy F Cloughesy; P Leia Nghiemphu
Journal:  J Neurooncol       Date:  2016-02-27       Impact factor: 4.130

2.  Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patients.

Authors:  James S Cordova; Hui-Kuo G Shu; Zhongxing Liang; Saumya S Gurbani; Lee A D Cooper; Chad A Holder; Jeffrey J Olson; Brad Kairdolf; Eduard Schreibmann; Stewart G Neill; Constantinos G Hadjipanayis; Hyunsuk Shim
Journal:  Neuro Oncol       Date:  2016-03-15       Impact factor: 12.300

Review 3.  Glioblastoma multiforme: Pathogenesis and treatment.

Authors:  Constantinos Alifieris; Dimitrios T Trafalis
Journal:  Pharmacol Ther       Date:  2015-05-02       Impact factor: 12.310

4.  SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.

Authors:  Stephanie M Robert; Susan C Buckingham; Susan L Campbell; Stefanie Robel; Kenneth T Holt; Toyin Ogunrinu-Babarinde; Paula P Warren; David M White; Meredith A Reid; Jenny M Eschbacher; Michael E Berens; Adrienne C Lahti; Louis B Nabors; Harald Sontheimer
Journal:  Sci Transl Med       Date:  2015-05-27       Impact factor: 17.956

Review 5.  Glutamate and tumor-associated epilepsy: glial cell dysfunction in the peritumoral environment.

Authors:  Susan C Buckingham; Stefanie Robel
Journal:  Neurochem Int       Date:  2013-02-04       Impact factor: 3.921

6.  Glutamate is associated with a higher risk of seizures in patients with gliomas.

Authors:  Tanya I Yuen; Andrew P Morokoff; Andrew Bjorksten; Giovanna D'Abaco; Lucy Paradiso; Sue Finch; Daniel Wong; Christopher A Reid; Kim L Powell; Kate J Drummond; Mark A Rosenthal; Andrew H Kaye; Terence J O'Brien
Journal:  Neurology       Date:  2012-07-25       Impact factor: 9.910

Review 7.  A role for glutamate in growth and invasion of primary brain tumors.

Authors:  Harald Sontheimer
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

8.  In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines.

Authors:  Hani J Marcus; Keri L H Carpenter; Stephen J Price; Peter J Hutchinson
Journal:  J Neurooncol       Date:  2009-08-28       Impact factor: 4.130

9.  Glutamate release by primary brain tumors induces epileptic activity.

Authors:  Susan C Buckingham; Susan L Campbell; Brian R Haas; Vedrana Montana; Stefanie Robel; Toyin Ogunrinu; Harald Sontheimer
Journal:  Nat Med       Date:  2011-09-11       Impact factor: 53.440

10.  Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema.

Authors:  Tina Sehm; Zheng Fan; Ali Ghoochani; Manfred Rauh; Tobias Engelhorn; Georgia Minakaki; Arnd Dörfler; Jochen Klucken; Michael Buchfelder; Ilker Y Eyüpoglu; Nicolai Savaskan
Journal:  Oncotarget       Date:  2016-06-14
View more
  1 in total

Review 1.  Membrane Transporters for Amino Acids as Players of Cancer Metabolic Rewiring.

Authors:  Mariafrancesca Scalise; Lara Console; Filomena Rovella; Michele Galluccio; Lorena Pochini; Cesare Indiveri
Journal:  Cells       Date:  2020-09-03       Impact factor: 6.600
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.